Hints and tips:
Related Special Reports
...Johnson & Johnson has struck a deal to buy medical device maker Shockwave Medical for $13.1bn, as the healthcare giant pursues acquisitions to bolster its medical technology arm....
...Johnson & Johnson has struck a deal to buy medical device maker Shockwave Medical for $13.1bn, as the healthcare giant puts cash to work from the spin-off of its consumer health arm to pursue acquisitions...
...Johnson & Johnson has raised its forecasts for the full year after it beat expectations on earnings and revenue, partly driven by soaring sales of cancer drugs in the US....
...Shareholders will soon be able to exchange some, all or none of their J&J stock for Kenvue at a 7 per cent discount. However, the exchange is subject to a limit of 8.0549 Kenvue shares....
...the [reproduction number] R....
...Johnson & Johnson is a very valuable company, notwithstanding its efforts to convince US federal judges of the contrary....
...Johnson & Johnson’s attempt to resolve tens of thousands of legal claims over talc powder products has been rejected for a second time....
...In his witness statement to the inquiry, Lord Lister said on Tuesday: “In September 2020, the R number was rising....
...Johnson & Johnson raised its full year profit forecast for 2023 on Thursday after reporting strong sales of cancer drugs and medical devices in the second quarter....
...“We are poised to become a leader in immuno-dermatology, with a broad pipeline including 14 active R&D programmes.”...
...Johnson & Johnson spun off consumer health unit Kenvue this year while GSK and Pfizer combined their consumer businesses to create Haleon in 2019....
...J&J advertisement (Child speaking) Johnson’s baby powder from Johnson & Johnson. It’ll keep you comfortable. Take it from a baby....
...Clip from NBC For further reading: Johnson & Johnson’s ‘Texas-two-step’ sparks outcry over US bankruptcy regime Talc ruling a blow to J&J and the ‘Texas two-step’ bankruptcy jig Talcum powder cancer...
...Johnson & Johnson’s newly formed consumer business has been targeted by claims that its talcum powder can cause cancer, days before it attempts to complete the largest US initial public offering in almost...
...Though classical in its scoring, it traverses the various music genres of the African diaspora — from west African drumming to gospel, jazz, soul and R&B — the aim being, says Witter-Johnson, to showcase...
...A US judge temporarily halted tens of thousands of legal claims that Johnson & Johnson’s talcum powder causes cancer from proceeding to trial on Thursday in a move that hands the company more time to agree...
...Shares of Kenvue, the consumer arm of healthcare giant Johnson & Johnson, jumped on their first day of trading after an upsized initial public offering that marked the biggest US listing in almost 18 months...
...Johnson & Johnson reported a first quarter loss on Tuesday as it booked a $6.9bn charge linked to its proposal to settle tens of thousands legal claims that its talcum powder caused cancer....
...Johnson & Johnson reported a first-quarter loss as it booked a $6.9bn charge linked to its proposal to settle tens of thousands of legal claims related to allegations its talcum powder caused cancer....
...A group of law firms representing almost 70,000 claimants who allege Johnson & Johnson’s talcum powder caused their cancers have agreed to support a $8.9bn settlement with the healthcare products company...
...“Neither Johnson & Johnson, nor any of its subsidiaries are in any financial distress....
...Late on Tuesday, an affiliate of Johnson & Johnson filed for bankruptcy protection....
...A US appeals court has rejected an effort by Johnson & Johnson to reopen a bankruptcy case involving a unit facing huge claims over allegations that its talcum powder caused cancer....
...Another cash offer for the entire stake worth R$10bn came from J&F Investimentos....
International Edition